Abstract
The anti-oestrogenic potential of two nitrogen-mustard-containing compounds, I.C.I. 79792 and I.C.I. 85966, was studied. I.C.I. 85966 usually did not decrease specific binding of [3H]oestradiol by breast-tumour cytoplasmic proteins. I.C.I. 79792 decreased specific [3H]oestradiol binding, but not to the same extent as similar concentrations of I.C.I. 46474, diethylstilboestrol or dibutyldihydrostilboestrol.
Full text
PDF




Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cole M. P., Jones C. T., Todd I. D. A new anti-oestrogenic agent in late breast cancer. An early clinical appraisal of ICI46474. Br J Cancer. 1971 Jun;25(2):270–275. doi: 10.1038/bjc.1971.33. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Davies P., Griffiths K. Stimulation of ribonucleic acid polymerase activity in vitro by prostatic steroid-protein receptor complexes. Biochem J. 1973 Nov;136(3):611–622. doi: 10.1042/bj1360611. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Geynet C., Millet C., Truong H., Baulieu E. E. Estrogens and antiestrogens. Gynecol Invest. 1972;3(1):2–29. [PubMed] [Google Scholar]
- Hähnel R., Twaddle E., Ratajczak T. The influence of synthetic anti-estrogens on the binding of tritiated estradiol-17beta by cytosols of human uterus and human breast carcinoma. J Steroid Biochem. 1973 Nov;4(6):687–695. doi: 10.1016/0022-4731(73)90044-7. [DOI] [PubMed] [Google Scholar]
- Hähnel R., Twaddle E. The steroid specificity of the estrogen-receptor of human breast carcinoma. J Steroid Biochem. 1974 Apr;5(2):119–122. doi: 10.1016/0022-4731(74)90117-4. [DOI] [PubMed] [Google Scholar]
- Jensen E. V., DeSombre E. R. Estrogen-receptor interaction. Science. 1973 Oct 12;182(4108):126–134. doi: 10.1126/science.182.4108.126. [DOI] [PubMed] [Google Scholar]
- Jensen E. V., DeSombre E. R. Mechanism of action of the female sex hormones. Annu Rev Biochem. 1972;41:203–230. doi: 10.1146/annurev.bi.41.070172.001223. [DOI] [PubMed] [Google Scholar]
- Jensen E. V., Jacobson H. I., Smith S., Jungblut P. W., De Sombre E. R. The use of estrogen antagonists in hormone receptor studies. Gynecol Invest. 1972;3(1):108–123. doi: 10.1159/000301747. [DOI] [PubMed] [Google Scholar]
- Jensen E. V., Numata M., Brecher P. I., Desombre E. R. Hormone-receptor interaction as a guide to biochemical mechanism. Biochem Soc Symp. 1971;32:133–159. [PubMed] [Google Scholar]
- Lunan C. B., Green B. 3H-oestradiol uptake in vivo by human uterine endometrium: effect of tamoxifen (I.C.I. 46,474). Clin Endocrinol (Oxf) 1974 Oct;3(4):465–480. doi: 10.1111/j.1365-2265.1974.tb02818.x. [DOI] [PubMed] [Google Scholar]
- MARTIN R. G., AMES B. N. A method for determining the sedimentation behavior of enzymes: application to protein mixtures. J Biol Chem. 1961 May;236:1372–1379. [PubMed] [Google Scholar]
- McGuire W. L., DeLaGarza M. Similarity of the estrogen receptor in human and rat mammary carcinoma. J Clin Endocrinol Metab. 1973 Mar;36(3):548–552. doi: 10.1210/jcem-36-3-548. [DOI] [PubMed] [Google Scholar]
- Skidmore J., Walpole A. L., Woodburn J. Effect of some triphenylethylenes on oestradiol binding in vitro to macromolecules from uterus and anterior pituitary. J Endocrinol. 1972 Feb;52(2):289–298. doi: 10.1677/joe.0.0520289. [DOI] [PubMed] [Google Scholar]
- Terenius L. Anti-oestrogens and breast cancer. Eur J Cancer. 1971 Feb;7(1):57–64. doi: 10.1016/0014-2964(71)90095-8. [DOI] [PubMed] [Google Scholar]
- Terenius L., Ljungkvist I. Aspects on the mode of action of antiestrogens and antiprogestogens. Gynecol Invest. 1972;3(1):96–107. doi: 10.1159/000301746. [DOI] [PubMed] [Google Scholar]
- Ward H. W. Anti-oestrogen therapy for breast cancer: a trial of tamoxifen at two dose levels. Br Med J. 1973 Jan 6;1(5844):13–14. doi: 10.1136/bmj.1.5844.13. [DOI] [PMC free article] [PubMed] [Google Scholar]
